Lv7
4840 积分 2022-09-28 加入
Shifts in pharma’s therapeutic area focus
7天前
已完结
The landscape for therapeutic cancer vaccines
7天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
7天前
已完结
The therapeutic potential of orphan adhesion G-protein-coupled receptors
7天前
已完结
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
7天前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
7天前
已完结
Target identification and assessment in the era of AI
7天前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
7天前
已完结
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies
7天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
15天前
已完结
皖公网安备34019202002308
